Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial (vol 329, pg 296, 2023)

被引：1
|
作者：
Mccarthy, M. W.
Naggie, S.
Boulware, D. R.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 330卷 / 16期
关键词：
D O I：
10.1001/jama.2023.20908
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1589 / 1589
页数：1
相关论文
共 50 条
  • [31] Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial
    Carmen de la Rocha
    Marco A. Cid-López
    Blanca I. Venegas-López
    Sandra C. Gómez-Méndez
    Adriana Sánchez-Ortiz
    Alma M. Pérez-Ríos
    Ricardo A. Llamas-Velázquez
    Aidé I. Meza-Acuña
    Bárbara Vargas-Íñiguez
    Daniela Rosales-Galván
    Alejandra Tavares-Váldez
    Nizdali Luna-Gudiño
    Cinthia V. Hernández-Puente
    Jovana Milenkovic
    Cecilia Iglesias-Palomares
    Miriam Méndez-del Villar
    Gerardo A. Gutiérrez-Dieck
    Carlos G. Valderrábano-Roldán
    Jennefer Mercado-Cerda
    Jocelyn G. Robles-Bojórquez
    Arieh R. Mercado-Sesma
    BMC Infectious Diseases, 22
  • [32] Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial
    de la Rocha, Carmen
    Cid-Lopez, Marco A.
    Venegas-Lopez, Blanca, I
    Gomez-Mendez, Sandra C.
    Sanchez-Ortiz, Adriana
    Perez-Rios, Alma M.
    Llamas-Velazquez, Ricardo A.
    Meza-Acuna, Aide, I
    Vargas-Iniguez, Barbara
    Rosales-Galvan, Daniela
    Tavares-Valdez, Alejandra
    Luna-Gudino, Nizdali
    Hernandez-Puente, Cinthia, V
    Milenkovic, Jovana
    Iglesias-Palomares, Cecilia
    Mendez-Del Villar, Miriam
    Gutierrez-Dieck, Gerardo A.
    Valderrabano-Roldan, Carlos G.
    Mercado-Cerda, Jennefer
    Robles-Bojorquez, Jocelyn G.
    Mercado-Sesma, Arieh R.
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [33] Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
    Hermine, Olivier
    Mariette, Xavier
    Tharaux, Pierre-Louis
    Resche-Rigon, Matthieu
    Porcher, Raphael
    Ravaud, Philippe
    JAMA INTERNAL MEDICINE, 2021, 181 (01) : 32 - 40
  • [34] Efficacy of combination therapy of fluvoxamine and favipiravir vs favipiravir monotherapy to prevent severe COVID-19 among mild to moderate COVID-19 patients: Open-label randomized controlled trial (EFFaCo study)
    Siripongboonsitti, Taweegrit
    Ungtrakul, Teerapat
    Tawinprai, Kriangkrai
    Nimmol, Tararin
    Buttakosa, Mullika
    Sornsamdang, Gaidganok
    Jarrusrojwuttikul, Tanadul
    Silapant, Phumin
    Mahanonda, Nithi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 134 : 211 - 219
  • [35] Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Crippa, Jose Alexandre S.
    Pacheco, Julia Cozar
    Zuardi, Antonio W.
    Guimaraes, Francisco S.
    Campos, Alline Cristina
    Lima Osorio, Flavia de
    Loureiro, Sonia Regina
    dos Santos, Rafael G.
    Souza, Jose Diogo S.
    Ushirohira, Juliana Mayumi
    Ferreira, Rafael Rinaldi
    Mancini Costa, Karla Cristinne
    Scomparin, Davi Silveira
    Scarante, Franciele Franco
    Pires-Dos-Santos, Isabela
    Mechoulam, Raphael
    Kapczinski, Flavio
    Fonseca, Benedito A. L.
    Esposito, Danillo L. A.
    Costa Passos, Afonso Dinis
    Dal Fabbro, Amaury Lelis
    Bellissimo-Rodrigues, Fernando
    Arruda, Eurico
    Scarpelini, Sandro
    Andraus, Maristela Haddad
    Nather Junior, Julio Cesar
    Wada, Danilo Tadao
    Koenigkam-Santos, Marcel
    Santos, Antonio Carlos
    Busatto Filho, Geraldo
    Hallak, Jaime E. C.
    CANNABIS AND CANNABINOID RESEARCH, 2022, 7 (05) : 658 - 669
  • [36] In mild to moderate COVID-19, VV116 safely reduced time to sustained clinical symptom resolution
    Granwehr, Bruno Palma
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (03) : JC35 - JC35
  • [37] Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease A Randomized Clinical Trial
    Koch, Giacomo
    Motta, Caterina
    Bonni, Sonia
    Pellicciari, Maria Concetta
    Picazio, Silvia
    Casula, Elias Paolo
    Maiella, Michele
    Di Lorenzo, Francesco
    Ponzo, Viviana
    Ferrari, Clarissa
    Scaricamazza, Eugenia
    Caltagirone, Carlo
    Martorana, Alessandro
    JAMA NETWORK OPEN, 2020, 3 (07)
  • [38] Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
    Gupta, Anil
    Gonzalez-Rojas, Yaneicy
    Juarez, Erick
    Casal, Manuel Crespo
    Moya, Jaynier
    Falci, Diego Rodrigues
    Sarkis, Elias
    Solis, Joel
    Zheng, Hanzhe
    Scott, Nicola
    Cathcart, Andrea L.
    Parra, Sergio
    Sager, Jennifer E.
    Austin, Daren
    Peppercorn, Amanda
    Alexander, Elizabeth
    Yeh, Wendy W.
    Brinson, Cynthia
    Aldinger, Melissa
    Shapiro, Adrienne E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (13): : 1236 - 1246
  • [39] Faster clinical recovery with ensovibep compared to placebo in patients with mild-to-moderate COVID-19: interim results from the EMPATHY Phase 2 trial
    Chandra, R.
    Abrishamian, L.
    Bonten, M.
    Fustier, P.
    Gedif, K.
    Goncalves, S.
    Igbinadolor, A.
    Kingsley, J.
    Knutson, C.
    Kumarasamy, N.
    Legenne, P.
    Mekebeb-Reuter, M.
    Ramanathan, K.
    Reshetnyak, E.
    Rosa, J.
    Soergel, M.
    Elango, D. Solai
    Stavropoulou, V.
    Stojcheva, N.
    Stumpp, M.
    Tietz, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [40] Author Correction: An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
    Rajan Ravichandran
    Surapaneni Krishna Mohan
    Suresh Kumar Sukumaran
    Devakumar Kamaraj
    Sumetha Suga Daivasuga
    Samson Oliver Abraham Samuel Ravi
    Sivakumar Vijayaraghavalu
    Ramarathnam Krishna Kumar
    Scientific Reports, 12
12345